Advances in the computational landscape for repurposed drugs against COVID-19
Author:
Funder
National Institutes of Health
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference157 articles.
1. The trinity of COVID-19: immunity, inflammation and intervention;Tay;Nat Rev Immunol,2020
2. The genetic sequence, origin, and diagnosis of SARS-CoV-2;Wang;Eur J Clin Microbiol Infect Dis,2020
3. Comprehensive analysis of drugs to treat SARS-CoV-2 infection: mechanistic insights into current COVID-19 therapies (Review);Nitulescu;Int J Mol Med,2020
4. ACE2 & TMPRSS2 expressions in head & neck tissues: a systematic review;Lechien;Head Neck Pathol,2021
5. Genotype and phenotype of COVID-19: their roles in pathogenesis;Mousavizadeh;J Microbiol Immunol Infect,2021
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Effectiveness of Drug Repurposing and Natural Products Against SARS-CoV-2: A Comprehensive Review;Clinical Pharmacology: Advances and Applications;2024-01
2. Favipiravir vs. Deferiprone: Tautomeric, photophysical, in vitro biological studies, and binding interactions with SARS-Cov-2-MPro/ACE2;Current Research in Biotechnology;2024
3. Determining the rate of infectious disease testing through contagion potential;PLOS Global Public Health;2023-08-02
4. MEDIATE - Molecular DockIng at homE: Turning collaborative simulations into therapeutic solutions;Expert Opinion on Drug Discovery;2023-07-10
5. Development of complemented comprehensive networks for rapid screening of repurposable drugs applicable to new emerging disease outbreaks;Journal of Translational Medicine;2023-06-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3